Popular filter options for truvada trials
Phase 3 Clinical Trials
View 16 phase 3 medical studies.
Virus Therapy
Lenacapavir for HIV Prevention
Recruiting1 awardPhase 3
Los Angeles, California
This trial will study the effectiveness of a new drug, lenacapavir, in preventing HIV infection in people who are at risk. The trial will have two parts: a cross-sectional study to estimate the background HIV infection rate, and a double-blind, randomized study to study the drug.
Antiretroviral
PrEP for HIV Prevention in Transgender Women
Recruiting3 awardsPhase 2 & 3
San Francisco, California
This trial will test a new strategy to improve PrEP uptake and adherence among transgender people by integrating biomedical HIV prevention with gender-affirming transgender care and Peer Health Navigation using Strengths-Based Case Management.
Behavioral Intervention
Digital Pill + Smartphone Intervention for HIV Prevention in Substance Users
Recruiting2 awardsPhase 3
Boylston, Massachusetts
This trial will test a new smartphone intervention for people taking PrEP, a daily pill to prevent HIV. The intervention will provide real-time feedback on pill-taking and offer counseling for people who miss doses.
Antiviral
F/TAF for HIV Pre-Exposure Prophylaxis
Recruiting1 awardPhase 3
Beverly Hills, California
This trial is testing whether a daily pill regimen of either emtricitabine/tenofovir alafenamide or emtricitabine/tenofovir disoproxil fumarate can help prevent HIV-1 infection in Men who have sex with men and transgender women.
Clinical Trials With No Placebo
View 16 medical studies that do not have a placebo group.
Antiretroviral Agent
PrEP + Hormone Therapy for HIV Prevention in Transgender Women
Recruiting1 awardPhase 1
Baltimore, Maryland
This trial is to study the best way to dose Truvada®, an oral medication that can be taken as Pre-Exposure Prophylaxis (PrEP) to prevent HIV infection, in transgender women who are also taking feminizing hormones.
Antiretroviral
PrEP for HIV Prevention in Transgender Women
Recruiting3 awardsPhase 2 & 3
San Francisco, California
This trial will test a new strategy to improve PrEP uptake and adherence among transgender people by integrating biomedical HIV prevention with gender-affirming transgender care and Peer Health Navigation using Strengths-Based Case Management.
Behavioral Intervention
Digital Pill + Smartphone Intervention for HIV Prevention in Substance Users
Recruiting2 awardsPhase 3
Boylston, Massachusetts
This trial will test a new smartphone intervention for people taking PrEP, a daily pill to prevent HIV. The intervention will provide real-time feedback on pill-taking and offer counseling for people who miss doses.
Antiretroviral
Stribild +1 More for HIV/AIDS
Recruiting5 awardsPhase 4
Honolulu, Hawaii
Atripla and Stribild are two FDA-Approved one pill a day combination antiretroviral medications given for the treatment of HIV. Both drugs are reasonably well tolerated. However, efavirenz, a component of Atripla, is known to cause "mental" side effects. This proposal aims to assess whether a switch from Atripla to Stribild for 12 weeks will be associated with reversal of sleep and cognitive disturbances. Demonstrating changes upon withdrawal of drug and substitution of a drug regimen not known to have an impact on sleep and cognition may represent the best option to determine whether use of efavirenz is associated with effects on sleep and cognition beyond the immediate period following initiation of drug.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.